Dr. An is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
620 John Paul Jones Circle
Hematology Oncology
Portsmouth, VA 23708Phone+1 757-953-1043
Education & Training
- National Capital ConsortiumFellowship, Hematology and Medical Oncology, 2016 - 2019
- Naval Medical Center (San Diego)Residency, Internal Medicine, 2012 - 2014
- Naval Medical Center (San Diego)Internship, Internal Medicine, 2011 - 2012
- A. T. Still University Kirksville College of Osteopathic MedicineClass of 2011
Certifications & Licensure![](https://directory.doximity.com/assets/icons/icon-help-e9f0b148a1e6d1f037dde9f26f025c36bd7c99fd4fe31fd76792996fa2aa5e66.svg)
- WV State License 2022 - 2026
- CA State License 2012 - 2023
- NC State License 2021 - 2022
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- ATM-deficient murine thymic T-cell lymphoblastic lymphomas are PTEN-deficient and require AKT signaling for survival.Joseph B An, Karen S Hathcock, Seth M Steinberg, Hyoyoung M Choo-Wosoba, Richard J Hodes
Plos One. 2024-01-01 - 7 citationsVenetoclax in upfront induction therapy for primary plasma cell leukemia with t(11;14) or BCL2 expression.Tina Roy, Joseph B An, Kimberly Doucette, Aimee M Chappell, David H Vesole
Leukemia & Lymphoma. 2022-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: